Haemonetics Corporation (HAE)

Fixed asset turnover

		Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	US$ in thousands	2,594,610	2,323,320	985,896	860,363	972,079
Property, plant and equipment	US$ in thousands	311,362	310,885	258,482	217,559	253,399
Fixed asset turnover		8.33	7.47	3.81	3.95	3.84

March 31, 2024 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $2,594,610K ÷ $311,362K
= 8.33

Haemonetics Corporation's fixed asset turnover ratio has shown a positive trend over the five-year period from 2020 to 2024. The ratio increased consistently from 3.84 in 2020 to 8.33 in 2024, indicating that the company generated $8.33 in sales revenue for every dollar invested in fixed assets in 2024. This suggests improved efficiency in utilizing fixed assets to generate revenue and reflects positively on the company's operational performance. The notable improvement in the fixed asset turnover ratio signifies that Haemonetics Corporation has effectively managed its fixed assets to drive sales growth and enhance overall productivity.